Src-Dependent DBL Family Members Drive Resistance to Vemurafenib in Human Melanoma

Charlotte R Feddersen1, Jacob L Schillo1, Afshin Varzavand2

  • 1Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, Iowa.

Cancer Research
|August 17, 2019
PubMed

Insights

Drug resistance is common in melanoma patients treated with BRAF inhibitors. A genetic screen identified a DBL/RAC1/PAK signaling pathway driving this resistance, which can be blocked by saracatinib, offering new combination therapy options.

Area of Science:

  • Oncology
  • Genetics
  • Pharmacology

Background:

  • Selective BRAF inhibitors (BRAFi) show efficacy in advanced cutaneous melanoma with BRAF mutations.
  • Acquired drug resistance limits the long-term effectiveness of BRAFi therapy in most patients.

Purpose of the Study:

  • To identify novel gain-of-function mechanisms driving BRAFi resistance in melanoma.
  • To explore potential therapeutic strategies to overcome BRAFi resistance.

Main Methods:

  • Utilized a genetic screening approach in two independent melanoma cell lines to identify resistance drivers.
  • Conducted mechanistic studies to elucidate the function of identified resistance genes.
  • Tested the efficacy of a SRC inhibitor (saracatinib) in blocking resistance.

Main Results:

  • Identified known and novel drivers of BRAFi resistance, including DBL family members.
  • Discovered a DBL/RAC1/PAK signaling axis mediating resistance to current and next-generation BRAFis.
  • Demonstrated that saracatinib effectively inhibits DBL-driven BRAFi resistance.

Conclusions:

  • A straightforward genetic screening method can rapidly identify genes conferring resistance to MAPK inhibitors.
  • The DBL/RAC1/PAK pathway is a key mediator of acquired BRAFi resistance in melanoma.
  • Saracatinib represents a potential therapeutic agent for combination therapy to overcome BRAFi resistance.

Related Concept Videos

Protein Families02:47

Protein Families

Protein families are groups of homologous proteins; that is, they have similarities in amino acid sequences and three-dimensional structures. Protein families usually occur because of gene duplication, where an additional copy of a gene is inserted into the genome of an organism.   Mutations that change the amino acids but still allow the protein to be properly synthesized, will lead to new protein family members.   If these new proteins contain similar amino acids in key...
16.7K
Protein Families02:47

Protein Families

4.3K
Gene Families01:57

Gene Families

Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
9.8K
Gene Families01:57

Gene Families

3.5K
Family Therapy01:30

Family Therapy

Family therapy conceptualizes psychological challenges as arising from dysfunctional interactions within the family unit, rather than as isolated issues within individuals. This approach seeks to address and transform the patterns of communication, roles, and relationships within families to promote healthier dynamics and emotional well-being for all members.
Strategic Family Therapy
Strategic family therapy emphasizes resolving communication barriers and improving problem-solving abilities...
524
Energy to Drive Translocation01:37

Energy to Drive Translocation

Mitochondrial protein import is powered by two distinct energy sources: ATP hydrolysis and electrochemical potential across the inner membrane. Newly synthesized precursors are bound by cytosolic chaperones of the Hsp70 family, which guide them to the import receptors on the mitochondrial surface. Utilizing the energy of ATP hydrolysis, Hsp70 chaperones transfer these precursors to the TOM receptors on the mitochondrial outer membrane.
Generally, polypeptides are unfolded by two distinct...
2.7K